SlideShare a Scribd company logo
1 of 1
Download to read offline
Yeast model of RNA binding proteins containing putative
prion-like domains in neurodegenerative diseases
Brittani M. Watkins. Amy E. Boncella, and Eric D. Ross
Department of Biochemistry & Molecular Biology, Colorado State University, Fort Collins, CO 80523
Background Methods
Results
Discussion
References
• Recently, several RNA-binding proteins
(RBPs) have been linked to
neurodegenerative diseases, including
amyotrophic lateral sclerosis (ALS) and
Alzheimer’s1,2
• Remarkably many of these RBPs,
including those already linked to
disease, contain prion-like domains
(PrLDs)1,2
• Algorithms created for yeast prions have
been used for determining PrLDs within
the human genome3
Purpose
• To begin evaluating the likelihood of
these proteins causing disease, we use
yeast to visualize their aggregation
ability
• Once we determine aggregation ability,
we can begin making algorithm-based
mutations to promote or inhibit
aggregation
• Give insight into the process behind
pathogenic aggregate formation
• If aggregation is occurring for the full-
length protein or its PrLD, then we will
visualize foci within the yeast cells
• Need to visualize the nucleus within Atx2
constructs
• Human homologs G3BP and TIA-1 had
similar phenotypes to Drosophila Ras and
Rox8 proteins, respectively2
• Drosophila homologs seem to mimic
human version within yeast
• Determining PrLD boundaries will be
important for modeling causative
mutations
• Plan to remove PrLDs from Atx2 full length
to get different perspective of PrLD
boundaries.
1. King, O. D., Gitler, A. D., and Shorter, J. (2012) The tip of the iceberg:
RNA-binding proteins with prion-like domains in neurodegenerative
disease. Brain Research 1462, 61-80
2. Couthouis, J., Hart, M. P., Shorter, J., DeJesus-Hernandez, M., Erion R.,
Oristano, R., Liu, A. X., Ramos, D., Jethava, N., Hosangadi, D., Epstein, J.,
Chiang, A., Diaz, Z., Nakaya, T., Ibrahim, F., Kim, H., Solski, J. A., Williams,
K. L., Mojsilovic-Petrovic, J., Ingre, C., Boylan, K., Graff- Radford, N. R.,
Dickson, D. W., Clay-Falcone, D., Elman, L., McCluskey, L., Greene, R.,
Kalb, G. A., Blair, I. P., King, O. D., Bonini, N. M., Deerlin, V. V.,
Rademakers, R., Mourelatos, Z., and Gitler, A. D. (2011) A yeast
functional screen predicts new candidate ALS disease genes. PNAS 108,
20881-20890
3. Cascarina, S. M., and Ross, E. D. (2014) Yeast prions and human prion-
like proteins: sequence features and prediction methods. Cell. Mol. Life
Sci. 71, 2047-2063
Acknowledgments
• A huge thank you to Eric D. Ross and all
the members of the Ross laboratory for
insightful discussion
PrLDs
Image adapted from Cascarina and Ross, 2014 3
Full length
Atx2’s PrLDs
• GFP with no fusion was used as a negative control
• Atx2 showed one large focus or possibly diffuse
within nucleus
• Ras cytoplasmic foci but also diffuse background
• Rox8 showed multiple cytoplasmic foci
• PrLD1 and PrLD3 were diffuse
• PrLD2 showed ring-like structures
• None of the PrLDs showed the exact same
phenotype as full length Atx2

More Related Content

What's hot

Protein misfolding & diseases
Protein misfolding & diseasesProtein misfolding & diseases
Protein misfolding & diseasesDr. Syamprasad NP
 
Modelling gender-specific regulation of tau in Alzheimer’s disease
Modelling gender-specific regulation of tau in Alzheimer’s diseaseModelling gender-specific regulation of tau in Alzheimer’s disease
Modelling gender-specific regulation of tau in Alzheimer’s diseaseEnrico Glaab
 
Human genome
Human genomeHuman genome
Human genomeDansfera
 
Als Paper & Prion Protein Gene Expression
Als Paper & Prion Protein Gene ExpressionAls Paper & Prion Protein Gene Expression
Als Paper & Prion Protein Gene Expressionjosephmdphysics
 
Human genome project 2007
Human genome project 2007Human genome project 2007
Human genome project 2007Hesham Gaber
 
Presentation1
Presentation1Presentation1
Presentation1afkhokher
 
The Models of Alzheimer's Disease Part III
The Models of Alzheimer's Disease Part IIIThe Models of Alzheimer's Disease Part III
The Models of Alzheimer's Disease Part IIIJimmy Lu
 
The Models of Alzheimer's Disease Part I
The Models of Alzheimer's Disease Part IThe Models of Alzheimer's Disease Part I
The Models of Alzheimer's Disease Part IJimmy Lu
 
Insects as Model in Aging Research
Insects as Model in Aging ResearchInsects as Model in Aging Research
Insects as Model in Aging ResearchBharati Singh
 
112 andrew fire - 7622633 - genetic inhibition by double-stranded rna
112   andrew fire - 7622633 - genetic inhibition by double-stranded rna112   andrew fire - 7622633 - genetic inhibition by double-stranded rna
112 andrew fire - 7622633 - genetic inhibition by double-stranded rnaMello_Patent_Registry
 
Schadt ad webinar (23 may 2013)
Schadt ad webinar (23 may 2013)Schadt ad webinar (23 may 2013)
Schadt ad webinar (23 may 2013)Alzforum
 
PROTEIN MISFOLDING AND DISEASES ASSOCIATED WITH THEM
PROTEIN MISFOLDING AND DISEASES ASSOCIATED WITH THEMPROTEIN MISFOLDING AND DISEASES ASSOCIATED WITH THEM
PROTEIN MISFOLDING AND DISEASES ASSOCIATED WITH THEMNaveenKumar654405
 

What's hot (20)

Is CRISPR a fear Against Sports?
Is CRISPR a fear Against Sports?Is CRISPR a fear Against Sports?
Is CRISPR a fear Against Sports?
 
Human genome
Human genomeHuman genome
Human genome
 
Protein misfolding & diseases
Protein misfolding & diseasesProtein misfolding & diseases
Protein misfolding & diseases
 
Modelling gender-specific regulation of tau in Alzheimer’s disease
Modelling gender-specific regulation of tau in Alzheimer’s diseaseModelling gender-specific regulation of tau in Alzheimer’s disease
Modelling gender-specific regulation of tau in Alzheimer’s disease
 
Jerry Shay, Telomere Testing
Jerry Shay, Telomere TestingJerry Shay, Telomere Testing
Jerry Shay, Telomere Testing
 
Human genome
Human genomeHuman genome
Human genome
 
Als Paper & Prion Protein Gene Expression
Als Paper & Prion Protein Gene ExpressionAls Paper & Prion Protein Gene Expression
Als Paper & Prion Protein Gene Expression
 
MSc dissertation
MSc dissertationMSc dissertation
MSc dissertation
 
Human genome project 2007
Human genome project 2007Human genome project 2007
Human genome project 2007
 
Presentation1
Presentation1Presentation1
Presentation1
 
The Models of Alzheimer's Disease Part III
The Models of Alzheimer's Disease Part IIIThe Models of Alzheimer's Disease Part III
The Models of Alzheimer's Disease Part III
 
The Models of Alzheimer's Disease Part I
The Models of Alzheimer's Disease Part IThe Models of Alzheimer's Disease Part I
The Models of Alzheimer's Disease Part I
 
Insects as Model in Aging Research
Insects as Model in Aging ResearchInsects as Model in Aging Research
Insects as Model in Aging Research
 
Vascular_Poster
Vascular_PosterVascular_Poster
Vascular_Poster
 
Introduction to GATA2 gene
Introduction to GATA2 geneIntroduction to GATA2 gene
Introduction to GATA2 gene
 
Essay 1
Essay 1Essay 1
Essay 1
 
112 andrew fire - 7622633 - genetic inhibition by double-stranded rna
112   andrew fire - 7622633 - genetic inhibition by double-stranded rna112   andrew fire - 7622633 - genetic inhibition by double-stranded rna
112 andrew fire - 7622633 - genetic inhibition by double-stranded rna
 
Schadt ad webinar (23 may 2013)
Schadt ad webinar (23 may 2013)Schadt ad webinar (23 may 2013)
Schadt ad webinar (23 may 2013)
 
PROTEIN MISFOLDING AND DISEASES ASSOCIATED WITH THEM
PROTEIN MISFOLDING AND DISEASES ASSOCIATED WITH THEMPROTEIN MISFOLDING AND DISEASES ASSOCIATED WITH THEM
PROTEIN MISFOLDING AND DISEASES ASSOCIATED WITH THEM
 
Bio341.Final.new
Bio341.Final.newBio341.Final.new
Bio341.Final.new
 

Viewers also liked (13)

Physiology nobel laureates
Physiology nobel laureatesPhysiology nobel laureates
Physiology nobel laureates
 
BDSRA 2015 CLN1 Wishart
BDSRA 2015 CLN1 Wishart BDSRA 2015 CLN1 Wishart
BDSRA 2015 CLN1 Wishart
 
Lincl katz
Lincl katzLincl katz
Lincl katz
 
finalposter_ARUKpdf
finalposter_ARUKpdffinalposter_ARUKpdf
finalposter_ARUKpdf
 
PROTEIN TARGETING
PROTEIN TARGETINGPROTEIN TARGETING
PROTEIN TARGETING
 
!Mechanism of protein sorting & targeting.
!Mechanism of protein sorting & targeting.!Mechanism of protein sorting & targeting.
!Mechanism of protein sorting & targeting.
 
Protein targeting ajay
Protein targeting ajayProtein targeting ajay
Protein targeting ajay
 
Protein folding and aggregation
Protein folding and aggregationProtein folding and aggregation
Protein folding and aggregation
 
Protein structure, targeting and sorting
Protein structure, targeting and sortingProtein structure, targeting and sorting
Protein structure, targeting and sorting
 
Protein transport, targeting and sorting
Protein transport, targeting and sortingProtein transport, targeting and sorting
Protein transport, targeting and sorting
 
Neurodegenerative diseases
Neurodegenerative diseases Neurodegenerative diseases
Neurodegenerative diseases
 
Protein targeting
Protein targetingProtein targeting
Protein targeting
 
Protein sorting and targeting
Protein sorting and targetingProtein sorting and targeting
Protein sorting and targeting
 

Similar to CURC FINAL

Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim HagoodEpigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim HagoodSystemic JIA Foundation
 
FOLDING (Central dogma of genetics)
FOLDING (Central dogma of genetics) FOLDING (Central dogma of genetics)
FOLDING (Central dogma of genetics) Maria Giraldo
 
Strauss_et_al_2015_with_supp (1)
Strauss_et_al_2015_with_supp (1)Strauss_et_al_2015_with_supp (1)
Strauss_et_al_2015_with_supp (1)Abigail Benkert
 
Integrative bioinformatics analysis of Parkinson's disease related omics data
Integrative bioinformatics analysis of Parkinson's disease related omics dataIntegrative bioinformatics analysis of Parkinson's disease related omics data
Integrative bioinformatics analysis of Parkinson's disease related omics dataEnrico Glaab
 
Why Life is Difficult, and What We MIght Do About It
Why Life is Difficult, and What We MIght Do About ItWhy Life is Difficult, and What We MIght Do About It
Why Life is Difficult, and What We MIght Do About ItAnita de Waard
 
Hsiao-DevNeurobiol2014
Hsiao-DevNeurobiol2014Hsiao-DevNeurobiol2014
Hsiao-DevNeurobiol2014Katie K. Hsiao
 
Genetic regulation of human brain aging
Genetic regulation of human brain agingGenetic regulation of human brain aging
Genetic regulation of human brain agingAlzforum
 
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...HCS Pharma
 
04.19.2013.an.analytical.workflow.for.metagenomic.data.and.its.application.to...
04.19.2013.an.analytical.workflow.for.metagenomic.data.and.its.application.to...04.19.2013.an.analytical.workflow.for.metagenomic.data.and.its.application.to...
04.19.2013.an.analytical.workflow.for.metagenomic.data.and.its.application.to...Mitch Fernandez
 

Similar to CURC FINAL (20)

MOJPB-03-00085
MOJPB-03-00085MOJPB-03-00085
MOJPB-03-00085
 
Bio
BioBio
Bio
 
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim HagoodEpigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
 
FOLDING (Central dogma of genetics)
FOLDING (Central dogma of genetics) FOLDING (Central dogma of genetics)
FOLDING (Central dogma of genetics)
 
Vu-2015_tissue-plasticity-PNET
Vu-2015_tissue-plasticity-PNETVu-2015_tissue-plasticity-PNET
Vu-2015_tissue-plasticity-PNET
 
Vu-2015_tissue-plasticity-PNET
Vu-2015_tissue-plasticity-PNETVu-2015_tissue-plasticity-PNET
Vu-2015_tissue-plasticity-PNET
 
BioPosterPP
BioPosterPPBioPosterPP
BioPosterPP
 
mmc2
mmc2mmc2
mmc2
 
Strauss_et_al_2015_with_supp (1)
Strauss_et_al_2015_with_supp (1)Strauss_et_al_2015_with_supp (1)
Strauss_et_al_2015_with_supp (1)
 
Integrative bioinformatics analysis of Parkinson's disease related omics data
Integrative bioinformatics analysis of Parkinson's disease related omics dataIntegrative bioinformatics analysis of Parkinson's disease related omics data
Integrative bioinformatics analysis of Parkinson's disease related omics data
 
Poster_MKZ
Poster_MKZPoster_MKZ
Poster_MKZ
 
Human Genome
Human GenomeHuman Genome
Human Genome
 
Human genome
Human genomeHuman genome
Human genome
 
Why Life is Difficult, and What We MIght Do About It
Why Life is Difficult, and What We MIght Do About ItWhy Life is Difficult, and What We MIght Do About It
Why Life is Difficult, and What We MIght Do About It
 
Nrneph.2014.170
Nrneph.2014.170Nrneph.2014.170
Nrneph.2014.170
 
Human Genome Project
Human Genome ProjectHuman Genome Project
Human Genome Project
 
Hsiao-DevNeurobiol2014
Hsiao-DevNeurobiol2014Hsiao-DevNeurobiol2014
Hsiao-DevNeurobiol2014
 
Genetic regulation of human brain aging
Genetic regulation of human brain agingGenetic regulation of human brain aging
Genetic regulation of human brain aging
 
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
 
04.19.2013.an.analytical.workflow.for.metagenomic.data.and.its.application.to...
04.19.2013.an.analytical.workflow.for.metagenomic.data.and.its.application.to...04.19.2013.an.analytical.workflow.for.metagenomic.data.and.its.application.to...
04.19.2013.an.analytical.workflow.for.metagenomic.data.and.its.application.to...
 

CURC FINAL

  • 1. Yeast model of RNA binding proteins containing putative prion-like domains in neurodegenerative diseases Brittani M. Watkins. Amy E. Boncella, and Eric D. Ross Department of Biochemistry & Molecular Biology, Colorado State University, Fort Collins, CO 80523 Background Methods Results Discussion References • Recently, several RNA-binding proteins (RBPs) have been linked to neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and Alzheimer’s1,2 • Remarkably many of these RBPs, including those already linked to disease, contain prion-like domains (PrLDs)1,2 • Algorithms created for yeast prions have been used for determining PrLDs within the human genome3 Purpose • To begin evaluating the likelihood of these proteins causing disease, we use yeast to visualize their aggregation ability • Once we determine aggregation ability, we can begin making algorithm-based mutations to promote or inhibit aggregation • Give insight into the process behind pathogenic aggregate formation • If aggregation is occurring for the full- length protein or its PrLD, then we will visualize foci within the yeast cells • Need to visualize the nucleus within Atx2 constructs • Human homologs G3BP and TIA-1 had similar phenotypes to Drosophila Ras and Rox8 proteins, respectively2 • Drosophila homologs seem to mimic human version within yeast • Determining PrLD boundaries will be important for modeling causative mutations • Plan to remove PrLDs from Atx2 full length to get different perspective of PrLD boundaries. 1. King, O. D., Gitler, A. D., and Shorter, J. (2012) The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Research 1462, 61-80 2. Couthouis, J., Hart, M. P., Shorter, J., DeJesus-Hernandez, M., Erion R., Oristano, R., Liu, A. X., Ramos, D., Jethava, N., Hosangadi, D., Epstein, J., Chiang, A., Diaz, Z., Nakaya, T., Ibrahim, F., Kim, H., Solski, J. A., Williams, K. L., Mojsilovic-Petrovic, J., Ingre, C., Boylan, K., Graff- Radford, N. R., Dickson, D. W., Clay-Falcone, D., Elman, L., McCluskey, L., Greene, R., Kalb, G. A., Blair, I. P., King, O. D., Bonini, N. M., Deerlin, V. V., Rademakers, R., Mourelatos, Z., and Gitler, A. D. (2011) A yeast functional screen predicts new candidate ALS disease genes. PNAS 108, 20881-20890 3. Cascarina, S. M., and Ross, E. D. (2014) Yeast prions and human prion- like proteins: sequence features and prediction methods. Cell. Mol. Life Sci. 71, 2047-2063 Acknowledgments • A huge thank you to Eric D. Ross and all the members of the Ross laboratory for insightful discussion PrLDs Image adapted from Cascarina and Ross, 2014 3 Full length Atx2’s PrLDs • GFP with no fusion was used as a negative control • Atx2 showed one large focus or possibly diffuse within nucleus • Ras cytoplasmic foci but also diffuse background • Rox8 showed multiple cytoplasmic foci • PrLD1 and PrLD3 were diffuse • PrLD2 showed ring-like structures • None of the PrLDs showed the exact same phenotype as full length Atx2